Prevalencia del Diagnóstico Post-COVID-19 en el Centro Integral de Atención Provisional (FIGALI) durante el Primer Trimestre del 2021

[Prevalence of Post-COVID-19 Diagnosis in the Comprehensive Interim Care Center (FIGALI) during the First Quarter of 2021]
DOI: 10.37980/im.journal.rmdp.20221899
Publicado
2022-08-30

Descargas

Archivos adicionales

Autores/as

  • Diago Arcia Arcia De la Ossa Complejo Hospitalario Dr. Arnulfo Arias Madrid,CSS, Panamá, Panamá
  • Lyanne Gómez Ministerio de Salud, Los Santos, Panamá
  • Raúl Ng Fábrega Hospital Regional Rafael Hernández, David, Chiriquí, Panamá
  • Luis Felipe Velásquez González Ministerio de Salud de Panamá, San Miguelito, Panamá, Panamá

Palabras clave:

síndrome post-COVID-19, comorbilidades, oxigenoterapia

Keywords:

Post-COVID-19 syndrome, comorbilities, oxygen therapy

Resumen

Introducción: El Síndrome Post-COVID-19 ha sido la terminología mas acuñada para el diagnóstico de las secuelas que persisten por más de 3 meses posterior a la infección por el virus SARS-CoV-2. Objetivo: Determinar la prevalencia del Diagnóstico Post-COVID-19. Metodología: Estudio descriptivo, transversal, retrospectivo y observacional. El universo consiste en todos los pacientes mayores de edad hospitalizados que ameritaron oxigenoterapia en el Centro Integral de Atención Provisional para Pacientes Moderados COVID-19 (FIGALI) durante el primer trimestre de 2021. Se describen los datos demográficos, las comorbilidades, los principales síntomas persistentes y la asistencia a Clínicas Post-COVID.
Resultados: Predominaron los mayores a 50 años (66%), con una estadía promedio de 10 días, ameritando la mayoría (79%) oxigenoterapia de bajo flujo (COVID-19 moderado), con distribución equitativa del sexo y mayoría de los encuestados tenía un mínimo de 5 meses de egresados. Las principales comorbilidades reportados fueron la hipertensión arterial (57%) y la diabetes mellitus (31%). La prevalencia del Diagnóstico Post-COVID-19 fue de 74% (131/177), siendo la fatiga, la tos y la disnea los principales síntomas reportados (45%, 32%, 29%) respectivamente. En el aspecto neuro-psiquiátrico se evidencia la ansiedad con un 18% y la depresión en 14% de los pacientes encuestados. Conclusiones: tres de cada cuatro pacientes que ameritaron oxigenoterapia, han persistido con al menos 1 síntoma luego de más de 5 meses de haber estado hospitalizado, siendo la fatiga el predominante. A pesar de la alta prevalencia descrita en este estudio, tan solo uno de cada cuatro pacientes, reporta haber acudido a Clínicas Post-COVID.


Abstract

Introduction: Post-COVID-19 Syndrome has been the most coined terminology for the diagnosis of sequelae that persist for more than 3 months following SARS-CoV-2 virus infection. Objective: To determine the prevalence of post-COVID-19 diagnosis. Methodology: Descriptive, cross-sectional, retrospective, and observational study. The universe consists of all hospitalized patients of legal age who required oxygen therapy at the Centro Integral de Atención Provisional para Pacientes Moderados COVID-19 (FIGALI) during the first quarter of 2021. Demographic data, comorbidities, main persistent symptoms, and attendance to Post-COVID Clinics are described. Results: Predominantly those older than 50 years (66%), with an average stay of 10 days, most (79%) requiring low-flow oxygen therapy (moderate COVID-19), with equal distribution of sex and most respondents had a minimum of 5 months of discharge. The main comorbidities reported were hypertension (57%) and diabetes mellitus (31%). The prevalence of post-COVID-19 Diagnosis was 74% (131/177), with fatigue, cough and dyspnea being the main symptoms reported (45%, 32%, 29%) respectively. In the neuro-psychiatric aspect, anxiety was evident with 18% and depression in 14% of the patients surveyed. Conclusions: three out of four patients who required oxygen therapy persisted with at least one symptom more than 5 months after hospitalization, with fatigue being the predominant symptom. Despite the high prevalence described in this study, only one out of four patients reported having attended Post-COVID Clinics.

Citas

R&d blue print. (2020). Gcm teleconference. In Pneumonia of unknown etiology in Wuhan, China – Note for the Records - 10 January 2020 (pp. 1-2). Teleconference; WHO. Retrieved 12 April 2022, from https://www.who.int/publications/m/item/gcm-teleconference-on-pneumonia-of-unknown-etiology-in-wuhan-china-note-for-the-records---10-january-2020.

Mahmud, R., Rahman, M., Rassel, M., Monayem, F., Sayeed, S., Islam, M., & Islam, M. (2021). Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh. PLOS ONE, 16(4), e0249644. https://doi.org/10.1371/journal.pone.0249644

COVID-19 Map - Johns Hopkins Coronavirus Resource Center. Johns Hopkins Coronavirus Resource Center. (2022). Retrieved 16 June 2021, from https://coronavirus.jhu.edu/map.html.xxx[4] Halpin, S., McIvor, C., Whyatt, G., Adams, A., Harvey, O., & McLean, L. et al. (2020). Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation. Journal Of Medical Virology, 93(2), 1013-1022. https://doi.org/10.1002/jmv.26368

Morin, L., Savale, L., Pham, T., Colle, R., Figueiredo, S., & Harrois, A. et al. (2021). Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. JAMA, 325(15), 1525. https://doi.org/10.1001/jama.2021.3331

Fernández-de-las-Peñas, C., Palacios-Ceña, D., Gómez-Mayordomo, V., Cuadrado, M., & Florencio, L. (2021). Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification. International Journal Of Environmental Research And Public Health, 18(5), 2621. https://doi.org/10.3390/ijerph18052621

Raveendran, A., Jayadevan, R., & Sashidharan, S. (2021). Long COVID: An overview. Diabetes &Amp; Metabolic Syndrome: Clinical Research &Amp; Reviews, 15(3), 869-875. https://doi.org/10.1016/j.dsx.2021.04.007

Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X., Luo, J., Huang, Z., Tu, S., Zhao, Y., Chen, L., Xu, D., Li, Y., Li, C., Peng, L., Li, Y., … Cao, B. (2021). 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet (London, England), 397(10270), 220–232. https://doi.org/10.1016/S0140-6736(20)32656-8

Marshall, M. (2020). The lasting misery of coronavirus long-haulers. Nature, 585(7825), 339-341. https://doi.org/10.1038/d41586-020-02598-6

Xiong, Q., Xu, M., Li, J., Liu, Y., Zhang, J., Xu, Y., & Dong, W. (2021). Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clinical Microbiology And Infection, 27(1), 89-95. https://doi.org/10.1016/j.cmi.2020.09.023

Cares-Marambio, K., Montenegro-Jiménez, Y., Torres-Castro, R., Vera-Uribe, R., Torralba, Y., & Alsina-Restoy, X. et al. (2021). Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Chronic Respiratory Disease, 18, 147997312110022. https://doi.org/10.1177/14799731211002240

Liyanage-Don, N., Cornelius, T., Sanchez, J., Trainor, A., Moise, N., Wainberg, M., & Kronish, I. (2021). Psychological Distress, Persistent Physical Symptoms, and Perceived Recovery After COVID-19 Illness. Journal Of General Internal Medicine, 36(8), 2525-2527. https://doi.org/10.1007/s11606-021-06855-w

Martinez, L. (2020). Panamá inauguró primera clínica post-covid en América Latina. ECO NEWS, p. 1. Retrieved 18 July 2022, from https://www.ecotvpanama.com/programas/eco-news/panama-inauguro-primera-clinica-post-covid-en-america-latina_1_66130.